Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

about

Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients.

P2860

Q32183971-F7A89193-4A22-48A5-96C4-BC755E9F3F41 Q52578959-A59AEE27-698F-4F47-B33E-53338DA885AC

P2860

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

Item

http://www.wikidata.org/entity/Q36171074

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

@ast

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

@en

type

Item

label

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

@ast

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

@en

prefLabel

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

@ast

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

@en

P1476

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

@en

P2093

Rushikesh Sable

http://www.w3.org/2001/XMLSchema#string

Sandeep Pallerla

http://www.w3.org/2001/XMLSchema#string

Seetharama D Jois

http://www.w3.org/2001/XMLSchema#string

Ted Gauthier

http://www.w3.org/2001/XMLSchema#string

P2860

Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domain

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine

Structural Evidence for Loose Linkage between Ligand Binding and Kinase Activation in the Epidermal Growth Factor Receptor

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

A semiempirical free energy force field with charge-based desolvation

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

P304

914-924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJMECH.2016.10.015

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27769032

http://www.w3.org/2001/XMLSchema#string

P932

5148673

http://www.w3.org/2001/XMLSchema#string

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

about

P2860

P2860

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932